» Articles » PMID: 22101430

Natural Killer Cells Act As Rheostats Modulating Antiviral T Cells

Overview
Journal Nature
Specialty Science
Date 2011 Nov 22
PMID 22101430
Citations 338
Authors
Affiliations
Soon will be listed here.
Abstract

Antiviral T cells are thought to regulate whether hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections result in viral control, asymptomatic persistence or severe disease, although the reasons for these different outcomes remain unclear. Recent genetic evidence, however, has indicated a correlation between certain natural killer (NK)-cell receptors and progression of both HIV and HCV infection, implying that NK cells have a role in these T-cell-associated diseases. Although direct NK-cell-mediated lysis of virus-infected cells may contribute to antiviral defence during some virus infections--especially murine cytomegalovirus (MCMV) infections in mice and perhaps HIV in humans--NK cells have also been suspected of having immunoregulatory functions. For instance, NK cells may indirectly regulate T-cell responses by lysing MCMV-infected antigen-presenting cells. In contrast to MCMV, lymphocytic choriomeningitis virus (LCMV) infection in mice seems to be resistant to any direct antiviral effects of NK cells. Here we examine the roles of NK cells in regulating T-cell-dependent viral persistence and immunopathology in mice infected with LCMV, an established model for HIV and HCV infections in humans. We describe a three-way interaction, whereby activated NK cells cytolytically eliminate activated CD4 T cells that affect CD8 T-cell function and exhaustion. At high virus doses, NK cells prevented fatal pathology while enabling T-cell exhaustion and viral persistence, but at medium doses NK cells paradoxically facilitated lethal T-cell-mediated pathology. Thus, NK cells can act as rheostats, regulating CD4 T-cell-mediated support for the antiviral CD8 T cells that control viral pathogenesis and persistence.

Citing Articles

The causal effect of natural killer cells on COVID-19 infection, hospitalization and severity.

Yang K, Quan J, Liu Z, Huang Z, Wang S, Li J Inflamm Res. 2025; 74(1):37.

PMID: 39945857 DOI: 10.1007/s00011-024-01967-5.


Inhibitory KIRs decrease HLA class II-mediated protection in Type 1 Diabetes.

Mora-Bitria L, Debebe B, Miners K, Ladell K, Kaur C, Traherne J PLoS Genet. 2024; 20(12):e1011456.

PMID: 39724143 PMC: 11741628. DOI: 10.1371/journal.pgen.1011456.


Emerging Insights into Memory Natural Killer Cells and Clinical Applications.

Kokici J, Preechanukul A, Arellano-Ballestero H, Gorou F, Peppa D Viruses. 2024; 16(11).

PMID: 39599860 PMC: 11599065. DOI: 10.3390/v16111746.


Germline natural killer cell receptors modulating the T cell response.

Mora-Bitria L, Asquith B Front Immunol. 2024; 15:1477991.

PMID: 39559364 PMC: 11570266. DOI: 10.3389/fimmu.2024.1477991.


T cell exhaustion methylation signature drives differential immune responses in glioblastoma.

Chen F, Qian W, Chen Z, Qian J, Luo C Discov Oncol. 2024; 15(1):530.

PMID: 39377985 PMC: 11461406. DOI: 10.1007/s12672-024-01412-3.


References
1.
Pircher H, Mak T, Lang R, Ballhausen W, Ruedi E, Hengartner H . T cell tolerance to Mlsa encoded antigens in T cell receptor V beta 8.1 chain transgenic mice. EMBO J. 1989; 8(3):719-27. PMC: 400867. DOI: 10.1002/j.1460-2075.1989.tb03431.x. View

2.
Martin M, Gao X, Lee J, Nelson G, Detels R, Goedert J . Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet. 2002; 31(4):429-34. DOI: 10.1038/ng934. View

3.
Exley M, Bigley N, Cheng O, Shaulov A, Tahir S, Carter Q . Innate immune response to encephalomyocarditis virus infection mediated by CD1d. Immunology. 2003; 110(4):519-26. PMC: 1783078. DOI: 10.1111/j.1365-2567.2003.01779.x. View

4.
Oldstone M . Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr Top Microbiol Immunol. 2002; 263:83-117. DOI: 10.1007/978-3-642-56055-2_6. View

5.
Oxenius A, Bachmann M, Ashton-Rickardt P, Tonegawa S, Zinkernagel R, Hengartner H . Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur J Immunol. 1995; 25(12):3402-11. DOI: 10.1002/eji.1830251230. View